We are excited to be able to share the following article provided by a member of the GRACE Fellows Ambassador Program, Dr. Arjun Gupta. The article, originally written for JAMA Oncology, is an amazing and warm piece about Dr. Gupta's experience with his first patient as a first-year oncology fellow. To view the full article on the JAMA website, please follow this link, or scroll down to see the full text. We are very much looking forward to collaborating with Dr. Gupta on supportive care...
We couldn't do what we do without you, our volunteers! From helping at the ASCO booth, admin and transcription work, to spreading pamphlets and information about GRACE, we have been lucky enough to meet some of the most amazing people. This month we are pleased to give a gracious nod and a huge thank you to Patrick Moroney. We first met Patrick at ASCO 2018 when he offered to help us work the booth at the yearly Chicago event. Pat Moroney lives in the Chicago area with his wife Eileen, who has...
GRACE is pleased to announce the acceptance of two rising stars in to the inaugural GRACE Fellows Ambassador Program for the 2019-2020 Program Year! Both candidates have shown a genuine passion for patient education and innovation in connecting with the patient community. The program will encompass the participants creating content which will be featured on the GRACE website, working alongside GRACE faculty, Board and staff, and learning the most current and effective communication skills needed...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...